Revision 5
Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IHC-P

REACTIVITY:

H

SENSITIVITY:

Endogenous

MW (kDa):

60

Source/Isotype:

Rabbit IgG

UniProt ID:

#Q96DU3

Entrez-Gene Id:

114836

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunohistochemistry (Paraffin) 1:50 - 1:200

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

For a carrier-free (BSA and azide free) version of this product see product #53988.

Specificity / Sensitivity

SLAMF6/CD352 (E3H1E) XP® Rabbit mAb recognizes endogenous levels of total SLAMF6/CD352 protein. This antibody does not cross-react with SLAMF3/Ly9, SLAMF4/2B4, or SLAMF5/CD84 protein.

Species Reactivity:

Human

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human SLAMF6/CD352 protein.

Background

SLAMF6 (CD352/NTB-A) is a type-I transmembrane glycoprotein belonging to the signaling lymphocytic activation molecule (SLAM) family of immunomodulatory receptors. Like other members of the SLAM receptor family, SLAMF6 contains Ig-like domains within its extracellular region and conserved tyrosine-based signaling motifs within its intracellular domain that, when phosphorylated, bind to the SAP and EAT-2 signaling adaptors (1). SLAMF6 is expressed on the surface of multiple types of immune cells, such as those of the B, T, and NK lineages. Its activation is triggered by homotypic interactions involving its extracellular domain (1-3). Indeed, research studies have shown that in T cells, SLAMF6 engagement facilitates activation and cytokine production (4). Similarly, homotypic ligand-mediated engagement of SLAMF6 on NK cells activates signaling cascades that drive proliferation, cytotoxicity, and cytokine production (1,5-7).

  1. Bottino, C. et al. (2001) J Exp Med 194, 235-46.
  2. Fraser, C.C. et al. (2002) Immunogenetics 53, 843-50.
  3. Flaig, R.M. et al. (2004) J Immunol 172, 6524-7.
  4. Valdez, P.A. et al. (2004) J Biol Chem 279, 18662-9.
  5. Stark, S. and Watzl, C. (2006) Int Immunol 18, 241-7.
  6. Falco, M. et al. (2004) Eur J Immunol 34, 1663-72.
  7. Eissmann, P. and Watzl, C. (2006) J Immunol 177, 3170-7.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IHC-P: Immunohistochemistry (Paraffin)

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
SignalStain is a registered trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 5
#60859

SLAMF6/CD352 (E3H1E) XP® Rabbit mAb

Western Blotting Image 1: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Western blot analysis of extracts from various cell lines using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower). Negative expression of SLAMF6/CD352 protein in U-937 cells is consistent with the predicted expression pattern.
Western Blotting Image 2: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Western blot analysis of extracts from 293T cells, mock transfected (-) or transfected with a construct expressing Myc/DDK-tagged full-length human SLAMF6/CD352 (hSLAMF6/CD352-Myc/DDK; +), using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb (upper), Myc-Tag (71D10) Rabbit mAb #2278 (middle), or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Immunohistochemistry Image 1: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human colon carcinoma using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 2: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human neuroendocrine lung carcinoma using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 3: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human non-Hodgkin lymphoma using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 4: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human small cell carcinoma of the salivary gland using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 5: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human endometrioid adenocarcinoma using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 6: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human urothelial carcinoma using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 7: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human tonsil using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 8: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human small intestine using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 9: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human parathyroid using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.
Immunohistochemistry Image 10: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human esophageal carcinoma using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb (left) compared to concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (right).
Immunohistochemistry Image 11: SLAMF6/CD352 (E3H1E) XP® Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded 293T cell pellet, untransfected (left) or SLAMF6 transfected (middle), and Daudi cell pellet (right, positive) using SLAMF6/CD352 (E3H1E) XP® Rabbit mAb.